Billy holds a BSc in Biomedical Sciences from University College London. Prior to Avoro, Billy worked in equity research both at Piper Sandler covering specialty pharmaceuticals and JP Morgan covering small-and-mid cap biotechnology. He began his career as a Strategy Consultant at RxC International, a small boutique biopharma consulting group. Billy joined Avoro Capital in 2025 and is focused on biopharma and late-stage commercial biotech opportunities.
+1 212.937.4970
info@avorocapital.com